The UAE Patient Temperature Monitoring Market was valued at $3.24 Million in 2025 and projected to reach to $5.03 Million by 2030, representing a compound annual growth rate of 6.5%. The UAE patient temperature monitoring market is poised for sustained growth, supported by the nation's robust healthcare infrastructure and strategic investments in digital health technologies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UAE patient temperature monitoring market is valued at USD 3.24 million in 2025, with a projected CAGR of 6.5% through 2030, reaching USD 5.03 million by forecast end.
UAE's state-of-the-art healthcare facilities and government initiatives promoting digital health adoption are accelerating the integration of advanced temperature monitoring technologies across hospitals and clinics.
Healthcare providers in UAE are increasingly shifting toward non-invasive and continuous temperature monitoring solutions, driven by patient comfort preferences and clinical efficacy demands.
The UAE's commitment to smart healthcare ecosystems and IoT-enabled medical devices is creating significant opportunities for connected temperature monitoring solutions in both hospital and home care settings.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | HANDHELD TEMPERATURE MONITORING DEVICES (Product) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.7% from 2025 to 2030 |
| Largest Segment | HANDHELD TEMPERATURE MONITORING DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 2.45 (2025) |
| Revenue Forecast (Billions) | ~USD 3.38 (2030) |
| Segments Covered | Product |
1 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2029 | 2030 | 2031 | 2032 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| AMBULATORY CARE CENTERS | 2.22 | 2.4 | 2.51 | 3.04 | 3.21 | 3.39 | 3.59 | 5.2 |
| HOME CARE SETTINGS | 3.25 | 3.56 | 3.77 | 4.79 | 5.11 | 5.46 | 5.86 | 6.5 |
| HOSPITALS | 7.05 | 7.73 | 8.16 | 10.3 | 10.96 | 11.7 | 12.5 | 6.3 |
| OTHER END USERS | 0.74 | 0.8 | 0.82 | 0.93 | 0.96 | 1 | 1.04 | 3.5 |
| PRIMARY CENTERS | 1.4 | 1.5 | 1.55 | 1.8 | 1.87 | 1.96 | 2.05 | 4 |
| URGENT CARE CENTERS | 1.2 | 1.3 | 1.35 | 1.59 | 1.67 | 1.75 | 1.85 | 4.6 |
| TOTAL | 15.86 | 17.3 | 18.16 | 22.45 | 23.78 | 25.26 | 26.89 | 5.8 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GODREJ GROUP | India | Private Company | Home appliances (refrigerators, ACs, washing machines, small appliances),Commercial appliances and cooling (medical refrigerators, deep freezers, vending, institutional coolers),Construction, civil engineering, and green building services, |
| ENDRESS + HAUSER AG | Switzerland | Private Company | Process instrumentation (flow, level, pressure, temperature, analytical),Laboratory and bioanalytical instruments,Sensors (physical, chemical, biosensors) as components, |
| DRÄGERWERK AG & CO. KGAA | Germany | Public Company | Acute-care ventilation and respiratory support,Anaesthesia workstations and perioperative solutions,Patient monitoring and IT connectivity, |
| HELEN OF TROY | United States | Public Company | Home & Outdoor – OXO kitchen and organization,Home & Outdoor – Hydro Flask and insulated beverageware,Home & Outdoor – Osprey and outdoor packs/luggage, |
| MASIMO | United States | Private Company | SET & Rainbow SET pulse oximetry (devices + sensors),Advanced monitoring (brain, hemodynamic, regional oximetry, gas),Hospital Automation & connectivity (Patient SafetyNet, Iris, iSirona, UniView, Replica), |
| SOLVENTUM | United States | Public Company | Medsurg,Dental Solutions,Health Information Systems, |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| PAUL HARTMANN AG | Germany | Public Company | Wound Care,Incontinence Management,Infection Management, |
| MICROLIFE CORPORATION | Taiwan | Private Company | Blood pressure monitors and accessories,Digital and infrared thermometers,Asthma and respiratory monitoring (peak flow, oximeters, nebulizers, software), |
Godrej Group is a private Indian conglomerate founded in 1897 with 13,316 employees, operating across multiple business sectors.
Endress + Hauser AG is a Swiss private company established in 1953 with 17,046 employees, specializing in measurement and automation technology.
Drägerwerk AG & Co. KGaA is a German public company founded in 1889 with 16,033 employees, operating in medical and safety technology sectors.
Helen of Troy is a United States-based public company founded in 1968 with 1,854 employees, engaged in consumer products manufacturing and distribution.
Masimo is a United States-based private company founded in 1989 with 2,200 employees, focused on non-invasive monitoring technologies.
Solventum is a United States-based public company founded in 2023 with 20,584 employees, operating in healthcare and industrial sectors.
Terumo Corporation is a Japanese public company founded in 1921 with 30,591 employees, specializing in medical devices and blood transfusion products.
Paul Hartmann AG is a German public company founded in 1818 with 10,066 employees, manufacturing medical and hygiene products.
Microlife Corporation is a Taiwan-based private company with 74 employees, engaged in medical device manufacturing.
The UAE patient temperature monitoring market is valued at USD 3.24 million in 2025 and is expected to grow to USD 5.03 million by 2030.
The UAE market is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2030.
Growth in the UAE is driven by advanced healthcare infrastructure, digital health adoption, rising chronic disease prevalence, and government support for precision medicine initiatives.
In the UAE, smart thermometers, wearable temperature sensors, and IoT-enabled monitoring devices are increasingly being adopted in hospitals, clinics, and home-care settings.
The UAE's regulatory environment, emphasis on digital health transformation, and high healthcare spending are creating favorable conditions for the development and deployment of advanced temperature monitoring solutions.
This study extensively used primary and secondary sources. The research process involved studying various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources such as National Institutes of Health (NIH), US FDA, World Health Organization (WHO), International Trade Administration (ITA), US Census Bureau, and Centers for Medicare and Medicaid Services (CMS) was referred to identify and collect information for the global patient temperature monitoring market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research phase, a comprehensive approach was employed, involving the interviewing of several sources from the supply and demand sides. These interviews aimed to obtain the quantitative and qualitative information needed to put up this report. Industry experts from core and associated industries, as well as preferred manufacturers, distributors, suppliers, technological innovators, and organizations involved in all facets of this industry's value chain, served as the primary information sources. Numerous primary respondents, including important industry participants, subject-matter specialists, C-level executives of the major market companies, and industry advisers, were the focus of extensive inquiry. The objective was to comprehensively evaluate potential futures and collect and validate significant qualitative and quantitative insights.
A breakdown of the primary respondents is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global patient temperature monitoring market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. The global patient temperature monitoring market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the global patient temperature monitoring market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Patient temperature monitoring involves the continuous or periodic assessment of an individual’s core body temperature to evaluate their physiological status, identify early manifestations of illness or infection, and inform clinical decision-making. This practice is integral to patient management across diverse healthcare environments, from primary care consultations to critical care units. It enables prompt recognition and intervention for thermoregulatory disturbances such as pyrexia or hypothermia, thereby enhancing overall patient outcomes through timely and targeted therapeutic responses.
Full forecast, segment splits, and company analysis for all Patient Temperature Monitoring Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report